The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men

Not Applicable

Completed

• Conditions: Human Immunodeficiency Virus; Cardiometabolic Risk
• Interventions: Behavioral: HOLA Component 1; Behavioral: HOLA Component 2; Behavioral: HOLA Component 3; Behavioral: HOLA Component 4

• Registration Number: NCT03839212
• Lead Sponsor: University of Miami

Brief Summary

The purpose of this study is to examine the feasibility of an intervention to prevent chronic diseases like diabetes, high blood pressure, and obesity in midlife and older Latino adults living with HIV. The investigators expect that the participant will be in this study for seven months. Participants will be interviewed and asked to take part in walking groups.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2019-02-08
• Study First Submitted QC: 2019-02-12
• Study First Posted: 2019-02-15
• Study Start: 2019-10-01
• Primary Completion: 2020-07-27
• Study Completion: 2020-10-27
• Status Verified: 2021-07
• Results First Submitted: 2021-07-21
• Results First Submitted QC: 2021-07-21
• Last Update Submitted: 2021-07-21
• Results First Posted: 2021-08-16
• Last Update Posted: 2021-08-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 18

Inclusion Criteria

• are Latino (self-identified);
• are age 50+ years;
• are male;
• are HIV infected but are virologically suppressed (viral load <200 copies/mL);
• volunteer informed consent;
• have medical clearance by a physician;
• expect to stay in Miami for the next 6 months; and
• have documented risk of cardiometabolic disease.

Read More

Exclusion Criteria

• diabetes diagnosis;
• at baseline meet criteria for current major depressive disorder or generalized anxiety disorder;
• meet criteria for current alcohol or other substance abuse disorders;
• have a lifetime history of bipolar disorder or other psychotic disorder;
• have a diagnosis of any neurodegenerative disorder or dementia (Parkinson's disease, Alzheimer's, vascular, frontotemporal dementia, etc.) or significant cognitive impairment as indicated by a Mini Mental Status Exam score <24;
• have contraindications to physical activity outlined in the American College of Sports Medicine standards;
• have high suicide risk i.e., intent or plan to attempt suicide in the near future (a response of "yes" to questions 3, 4, and/or 5 on the Paykel Questionnaire);
• are unable to complete 10 m walk test;
• currently residing in a nursing or group home;
• have a terminal physical illness expected to result in the death within one year;
• have an acute or severe medical illness that precludes them from safely participating in a health promotion intervention.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Happy Older Latinos are Active (HOLA)	HOLA Component 1	A 16-week multi-component, health promotion intervention
Happy Older Latinos are Active (HOLA)	HOLA Component 2	A 16-week multi-component, health promotion intervention
Happy Older Latinos are Active (HOLA)	HOLA Component 3	A 16-week multi-component, health promotion intervention
Happy Older Latinos are Active (HOLA)	HOLA Component 4	A 16-week multi-component, health promotion intervention

Primary Outcome Measures

Name	Time	Method
Retention Rate	Up to 3 months post intervention	Retention rate will be reported as the number of participants completing the post-intervention assessment.
Acceptability of Intervention	Up to week 16	As measured by the total number of sessions attended by the participants as a whole.
Number of Eligible Participants Refusing to Participate.	Baseline	Number of eligible participants refusing to participate.

Secondary Outcome Measures

Name	Time	Method
Change in Cardiometabolic Risk as Measured by Waist Circumference	Baseline, 7 months post intervention	As measured by the number of inches around the participant's waist. A waist circumference of 102 centimetres (40 inches) or more in men is associated with health problems such as type 2 diabetes, heart disease and high blood pressure.
Change in Health-related Quality of Life as Measured by the Short Form Health Survey (SF-12)	Baseline, Month 4, Month 7	The SF-12v2 is a measure of health related quality of life and provides 2 scores 1) Mental Component Summary Score (MCS) and 2) Physical Component Summary Score (PCS). MCS scores range from 0 to 100, higher scores indicate better mental health related quality of life.
Change in Psychosocial Functioning as Measured by Depression Severity Scale	Baseline, Month 4, Month 7	As measured by a 20-item Center for Epidemiologic Studies Depression (CES-D) scale. The possible range of scores are 0 to 60 with the higher scores indicating the presence of more symptomatology.
Change in Lipid Profile as Measured by Total Cholesterol, HDL-C, LDL-C, Triglycerides	Baseline, Month 4, Month 7	A total cholesterol value of less than 200 mg/dL (5.18 mmol/L) is desirable and 240 mg/dL (6.22 mmol/L) or higher is high. Average HDL-C level is 40-50 mg/dL (1.0-1.3 mmol/L) for men. Low HDL-C level, increased risk, is less than 40 mg/dL (1.0 mmol/L). Optimal LDL-C levels are less than 100 mg/d while high levels are 160-189 mg/dL (4.15-4.90 mmol/L). Desirable triglyceride levels are less than 150 mg/dL (1.70 mmol/L) while high levels are considered 200-499 mg/dL (2.3-5.6 mmol/L).
Change in Psychosocial Functioning as Measured by the Patient Health Questionnaire (PHQ-9)	Baseline, Month 4, Month 7	severity of depression will be measured by the 9-item PHQ-9. Scores range from 0 to 27. With scores of 1-4 indicating minimal depression and scores of 20-27 indicating severe depression.
Change in Psychosocial Functioning as Measured by the Severity of Anxiety Using the Generalized Anxiety Disorder Scale	Baseline, Month 4, Month 7	The 7-item Generalized Anxiety Disorder (GAD-7) scale will be used to measure the severity of anxiety. The scores range from 0 to 21 with scores of 0 to 5 indicating mild anxiety and scores of 15-21 indicating severe anxiety.
Change in Psychosocial Functioning as Measured by the Social Support Received	Baseline, Month 4, Month 7	The 12 item Multidimensional Scale of Perceived Social support. After calculating the mean score across the categories a mean scale support score from 1 to 2.9 would indicate low support, whereas a mean score of 5.1 to 7 would indicate high support.
Change in Glucose as Measured by Glycated Hemoglobin (Hba1c)	Baseline, Month 4, Month 7	The normal range for the hemoglobin A1c level is between 4% and 5.6%. Hemoglobin A1c levels between 5.7% and 6.4% mean a higher chance of getting diabetes. Levels of 6.5% or higher mean diabetes.
Change in Psychosocial Functioning as Measured by the Severity of Anxiety Using the Perceived Stress Scale	Baseline, Month 4, Month 7	The 14 item Healthy Families Program Perceived Stress Scale will be used to measure the severity of anxiety. PSS scores can range from 0 to 40 with higher scores indicated higher perception of stress.
Change in Hypertension as Measured by Systolic and Diastolic Blood Pressure.	Baseline, Month 4, Month 7	Normal systolic and diastolic pressure is less than 120 mmHg and 80mmHg, respectively. High systolic and diastolic pressure is 140 mmHg or higher and 90 mmHg or higher, respectively.

Trial Locations

Locations (1)

Jackson Memorial Mental Health Hospital; 🇺🇸 Miami, Florida, United States